Monoclonal antibodies as anti-infective products: a promising future?

Pelfrene E.; Mura M.; Sanches A. Cavaleiro; Cavaleri M.

首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Monoclonal antibodies as anti-infective products: a promising future?

【24h】

Monoclonal antibodies as anti-infective products: a promising future?

机译：单克隆抗体作为抗感染产品：未来有前途的未来？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: The paucity of licensed monoclonal antibodies (mAbs) in the infectious diseases arena strongly contrasts with the ready availability of these therapeutics for use in other conditions.

机译：背景：传染病竞技场中许可的单克隆抗体（MAb）的缺乏强烈对比这些治疗剂的现成可用性用于其他条件。

著录项

来源
《Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases》 |2019年第1期|共5页
作者
Pelfrene E.; Mura M.; Sanches A. Cavaleiro; Cavaleri M.;
展开▼
作者单位

European Med Agcy Human Med Evaluat Div Off Antiinfect &

Vaccines London England;

European Med Agcy Human Med Evaluat Div Off Antiinfect &

Vaccines London England;

European Med Agcy Human Med Res &

Dev Support Div Qual Off London England;

European Med Agcy Human Med Evaluat Div Off Antiinfect &

Vaccines London England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词
Antimicrobial resistance; Biothreats; Immunotherapy; Monoclonal antibody therapeutics; Multifunctional Antibodies;

机译：抗菌抗性;生物疗法;免疫疗法;单克隆抗体治疗;多功能抗体;

相似文献

外文文献
中文文献
专利

1. Monoclonal antibodies as anti-infective products: a promising future? [J] . Pelfrene E., Mura M., Sanches A. Cavaleiro, Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases . 2019,第1期

机译：单克隆抗体作为抗感染产品：未来有前途的未来？
2. Anti-infective monoclonal antibodies: perils and promise of development [J] . Janice M. Reichert, Matthew C. Dewitz Nature reviews Drug discovery . 2006,第3期

机译：抗感染单克隆抗体：危险和发展前景
3. Glycosylation of monoclonal antibody products: Current status and future prospects [J] . Batra Jyoti, Rathore Anurag S. Biotechnology Progress . 2016,第5期

机译：单克隆抗体产品的糖基化：现状和未来展望
4. REGISTRATION ENABLING CAMPAIGN FOR ACCELERATED DEVELOPMENT: A PPQ STRATEGY WITH MINIMAL EARLY INVESTMENTS TO ENABLE FAST TO MARKET DEVELOPMENT FOR A PROMISING MONOCLONAL ANTIBODY [C] . Jessica Wuu, Kristen Koterba Douglas Cell culture engineering conference . 2018

机译：注册有利于加速发展的营销活动：PPQ策略，早期投资最少，以实现市场快速发展的单克隆抗体的发展
5. Batch quality control of monoclonal antibody (MAB) product in mammalian cell-culture. [D] . Bawn, Andrew. 2012

机译：哺乳动物细胞培养中单克隆抗体（MAB）产品的批次质量控制。
6. Monoclonal antibodies as anti-infective products: a promising future? [O] . E. Pelfrene, M. Mura, A. Cavaleiro Sanches, -1

机译：单克隆抗体作为抗感染产品：前景广阔？
7. Monoclonal antibodies as anti-infective products: a promising future? [O] . E. Pelfrene, M. Mura, A. Cavaleiro Sanches, 2019

机译：单克隆抗体作为抗感染产品：未来有前途的未来？
8. Develop Systems for Manufacturing 100,000,000 Doses of an Emergency Pharmaceutical (e.g. Vaccine or Monoclonal Antibody) Within 2 Months of Product Identification [R] . Baldwin, T. , Estell, D. , Fung, J. , 2006

机译：在2个月的产品鉴定中开发制造100,000,000剂量的紧急药物（例如疫苗或单克隆抗体）的系统

Monoclonal antibodies as anti-infective products: a promising future?

摘要

著录项

相似文献

相关主题

期刊订阅